$600
The MTHFR test looks for common variations in the MTHFR gene (C677T and A1298C) that may affect the body’s ability to process folate (vitamin B9) and support healthy methylation — a key biochemical pathway involved in detoxification, neurotransmitter production, and cellular function.
While MTHFR variants are common in the general population and do not diagnose autism, some individuals with autism may benefit from understanding whether their folate and methylation pathways need extra nutritional support. When appropriate, results may help guide personalized nutrition plans using forms of folate and B-vitamins that are easier for the body to use.
Analysis of the two most clinically relevant MTHFR variants
C677T
A1298C
Clear explanation of whether 0, 1, or 2 copies of each variant are present
Guidance on how these results may relate to folate metabolism & methylation
Follow-up recommendations when appropriate
Some autistic individuals may experience challenges related to:
Folate metabolism
Methylation pathway efficiency
Detoxification support
Nutrient utilization
Folate metabolism
Methylation pathway efficiency
Detoxification support
Nutrient utilization
This test provides information only and does not diagnose autism or predict developmental outcomes. Results are always interpreted within the larger clinical picture.
Our Leucovorin Treatment Program is offered in-office as part of our biomedical services for autism. It includes:
Simple sample collection (cheek swab or blood test)
Certified laboratory analysis
Personalized review of results
Optional nutritional + treatment recommendations based on findings
Treatment is closely supervised and fully integrated into your child’s overall care plan.
Children with autism or developmental delays
Children with low folate/B-vitamin levels
Children with elevated homocysteine
Families pursuing a personalized, nutrition-focused approach
MTHFR variants are common and, by themselves, rarely cause medical problems. For many individuals, treatment involves general nutrition support regardless of genetic status.
This test is most helpful when interpreted alongside clinical symptoms and other lab findings such as homocysteine, folate, and B-vitamin levels.
$600
The Folate Receptor Antibody Test (FRAT) measures antibodies that can interfere with the body’s ability to transport folate into the brain. Folate is essential for healthy neurological development, cellular growth, and communication between brain cells.
In some individuals — including a notable subset of children with autism — these antibodies may reduce the amount of folate reaching the central nervous system. Identifying this condition can help guide whether targeted treatment with folinic acid (leucovorin) may be beneficial.
When folate cannot effectively cross the blood-brain barrier due to these antibodies, a condition called Cerebral Folate Deficiency (CFD) may occur.
Some children with CFD may experience:
Language delay
Irritability
Sleep disturbance
Motor or coordination challenges
Feeding and GI concerns
Research suggests that appropriate treatment may support improvement in some of these areas when CFD is present.
This test looks for:
Blocking antibodies (Antibodies that interfere with folate binding)
Binding antibodies (Antibodies attaching to folate receptor proteins)
Both may contribute to reduced folate transport into the brain.
Autism spectrum disorder
Developmental delay
Speech/language impairment
Neurological symptoms
Low folate in cerebrospinal fluid (when known)
A positive test may guide targeted therapeutic support with folinic acid (leucovorin) under clinician supervision.
Results include:
Presence / absence of folate receptor antibodies
Quantitative antibody levels
Whether CFD-guided treatment may be appropriate
This test does not diagnose autism but rather identifies a potentially reversible metabolic contributor in some individuals.
Simple blood draw
Certified laboratory analysis
Review of results with clinician
Individualized treatment discussion if indicated
If antibodies are found, families may be offered:
Trial of folinic acid (leucovorin)
Follow-up visits to monitor symptoms
Dose adjustments based on clinical response
Treatment decisions are individualized.
Not all autistic children have folate receptor antibodies.
A positive result does not guarantee benefit from treatment.
A negative result does not rule out methylation or folate-related challenges.
Interpretation is always done in context of your child’s full medical picture.